Health Care

THOMPSON: Push is on to regulate health information technologyRestricted Content

November 24, 2012
Bradley Merrill Thompson / Special to IBJ
After decades of slow adoption, health information technology now threatens to completely disrupt health care, in a good way, dramatically improving quality of care. The question is, will federal regulators stand in the way?
More

Dialysis software firm finally making inroadsRestricted Content

November 24, 2012
Scott Olson
Vasc-Alert proves its technology, plans to expand into Europe.
More

SCHAFIR: Businesses face tough decisions over health careRestricted Content

November 24, 2012
Harlan Schafir / Special to IBJ
Now that the election is over, it seems clearer that the Patient Protection and Affordable Care Act, or Obamacare, will likely move forward. The question is whether business owners will be able to steer their employees to state exchanges and wash their hands of health care coverage.
More

Indiana legislative leaders ponder health costs

November 19, 2012
Associated Press
Indiana's top lawmakers said Monday they're not sure what to expect from the federal health care law other than greater costs at a time the state's budget is already stretched thin.
More

Cook wins approval for new stent

November 19, 2012
J.K. Wall
Bloomington-based Cook Medical won approval for the first drug-coated stent for clogged leg arteries in the United States, which accounts for 40 percent of the soon-to-be $3 billion market.
More

Lilly donating $12.4 million to United Way

November 19, 2012
 IBJ Staff
Eli Lilly and Co. said Monday it plans to give $12.4 million to the United Way, the largest single charitable donation in the company’s history.
More

Lawmakers brace for health law, potential costs

November 18, 2012
Associated Press
Indiana lawmakers can add confusion over the federal health insurance law to their already overflowing plate when they return for their 2013 legislative session in January.
More

Pence solidifies opposition to state exchange

November 15, 2012
Associated Press
Indiana Gov.-elect Mike Pence closed the door on a state-run health insurance exchange Thursday, arguing that the estimated $50 million cost of the state program was not worth the limited autonomy granted in return.
More

Drugmakers collaborate to facilitate drug tests

November 15, 2012
Associated Press
Eli Lilly and Co. and two other major drugmakers say they are collaborating in a global project aimed at getting patient tests of experimental drugs up and running more quickly and efficiently.
More

Indy loses promising health startup

November 12, 2012
J.K. Wall
LabDoor, which soon will launch an iPhone app that assigns A-F grades to over-the-counter vitamins and medicines, moved last month from Indianapolis to San Francisco, where it received $100,000 in startup financing.
More

Health officials: Indiana needs more trauma centers

November 12, 2012
Associated Press
Health officials developing a statewide trauma system say Indiana needs more trauma centers.
More

Indiana's top state budget official finds new job

November 9, 2012
Associated Press
The top state budget official under Indiana Gov. Mitch Daniels has decided to move into an executive position with Indiana University Health when the governor's term ends in January.
More

WellPoint shares droop despite profitable quarter

November 7, 2012
Bloomberg News
WellPoint Inc.'s third-quarter earnings trumped Wall Street expectations, but the health insurer's stock tumbled Wednesday after President Barack Obama won re-election, a victory that could help cement the future of his health care overhaul.
More

Low enrollment clouds Healthy Indiana PlanRestricted Content

November 3, 2012
J.K. Wall
Many Indiana Republicans want to use the Healthy Indiana Plan to expand Medicaid coverage in Indiana to more low-income adults. But the program—which offers health insurance based on health savings accounts to uninsured adults—has managed to attract just one-third of the Hoosiers it was designed for and has cost about twice as much per enrollee as predicted.
More

Lilly to spend $140M on new insulin cartridge plant

November 1, 2012
J.K. Wall
About 100 workers will staff the new plant, which will be constructed by spring 2014 and ready for operations in 2015. But only “some” of that number will be new hires.
More

Lilly plans expansion of local insulin plant

October 30, 2012
J.K. Wall
The Indianapolis-based drugmaker plans to expand its local insulin plants to make insulin cartridges to meet what it describes as growing demand in the United States.
More

Lilly's Cialis receives European approval for new use

October 30, 2012
Associated Press
The European Union has approved Eli Lilly and Co.'s erectile dysfunction drug Cialis to treat symptoms tied to an enlarged prostate.
More

Colts QB Luck, Riley Hospital reach multiyear promotional deal

October 30, 2012
Anthony Schoettle
Indianapolis Colts rookie quarterback Andrew Luck on Tuesday will announce his first local sponsorship deal, a four-year pact with Riley Hospital for Children at Indiana University Health.
More

Zimmer trims full-year forecast after quarterly profit falls

October 25, 2012
J.K. Wall
The Warsaw-based maker of orthopedic implants beat analysts’ estimates with its third-quarter earnings, but lowered its full-year forecast.
More

Amerigroup shareholders approve $4.9B sale to WellPoint

October 24, 2012
J.K. Wall
Shareholders of Amerigroup Corp. overwhelming approved the Virginia company’s sale for $4.9 billion to Indianapolis-based health insurer WellPoint Inc. in a vote on Tuesday. The vote clears the way for the acquisition to close before the end of the year.
More

Lilly CEO calls for life sciences research institute

October 23, 2012
J.K. Wall
Eli Lilly CEO John Lechleiter on Tuesday called for creation of a "world-class" research institute in Indianapolis to bring together scientists from universities and corporations to develop new medical therapies and companies.
More

Lilly says experimental diabetes drug outperformed rivals

October 22, 2012
J.K. Wall
Eli Lilly and Co. said dulaglutide lowered blood sugar better than three existing diabetes drugs in three Phase 3 clinical trials. Analysts expect the drug to hit the market in 2014 or 2015 and become a blockbuster.
More

Alzheimer’s prevention seen promising as drug cures fail

October 19, 2012
Bloomberg News
Researchers are set to test drugs by Eli Lilly and other companies that may prevent Alzheimer’s disease after efforts to find a cure have been unsuccessful.
More

WellPoint reorganizes into four business units

October 11, 2012
Bloomberg News
Separate Medicare and Medicaid divisions each will sell plans for those government-backed insurance programs. Another will handle commercial and individual business, and a specialty unit will provide dental, vision and disability coverage.
More

Lilly, Roche drugs chosen for Alzheimer’s prevention trial

October 10, 2012
Bloomberg News
Eli Lilly & Co.’s solanezumab and Roche Holding AG’s gantenerumab were selected for a long-term Alzheimer’s trial run by Washington University at St. Louis scientists seeking to block the disease’s symptoms.
More
Page  << 11 12 13 14 15 16 17 18 19 20 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT